Child mortality growth in the UK between 62 and 400% since September

Child deaths have increased since the British started vaccinating teenagers 12 and older. The risk-benefit analysis raises serious doubts about administering the experimental drug to this age group.
On September 20, the UK health service NHS announced that it would introduce the coronavirus vaccine to children aged 12-15. In the largest vaccination campaign in UK healthcare history, nearly three million children can receive a first dose of Pfizer’s vaccine. According to the NHS, vaccinations have started in hundreds of schools (week 38) and the vaccination program will be rolled out to more schools in the coming weeks.

Increase in deaths:
After the government launched the vaccine, the UK’s National Statistics Office, ONS, found that the number of deaths in children ages 10-14 between Week 38 and Week 41 in 2021 was 62% above the five-year average for the number the number of deaths in this age group was over the same period. Also, the rise in deaths began when the children received the experimental “vaccine”.

The trend of increasing child deaths continues. In week 43 of 2021, more children in the 5-14 age group died than usual. UKHSA data recently showed that so many children died in late October that excess mortality occurred.

Is there any connection?
The decision to vaccinate children over the age of twelve came after the UK’s four Chief Medical Officers (CMOs) advised the government to offer them the Pfizer injection. The government decided to continue the vaccination program, despite the fact that the Joint Committee on Vaccination and Immunization (JCVI) had previously stated that it could not support general vaccination of children.

Is it just a coincidence that the number of child deaths has since increased by 62% (and 400% for children at risk) compared to the five-year average?

The CMO admit that they are unaware of the negative effects of the injection on children and state, “We acknowledge that there is considerable uncertainty about the extent of the potential harm”.

In considering whether or not to vaccinate children of this age, the CMOs state that vaccination will help “prevent class outbreaks and further disruptions in the classroom”. However, this line of argument lacks any factual basis; as the vaccination showed, it fails to prevent infection or transmission. Furthermore, Pfizer itself does not make the CMO’s claim. Hence, the government’s argument that the benefits outweigh the risks is not valid.

https://world-signals.com/news/2021/12/14/child-mortality-growth-in-the-uk-between-62-and-400-since-september/